Fig. 6.
Effects of pCMBS on 10 μM ADP-induced adenylyl cyclase inhibition in CHO-K1 cells stably expressing human platelet P2Y12 wild type and mutants.
Cells expressing the wild-type or mutant P2Y12 receptors were pretreated with pCMBS for 10 minutes at 37°C before the addition of 20 μM forskolin. Data were normalized to the value obtained with forskolin alone (mean, ± SE. *P > .05, ***P < .001 compared with forskolin 20 μM + ADP 10 μM by t test).